Jennifer Richardson

Title: Jennifer Richardson: Innovator in Feline Immunodeficiency Research

Introduction

Jennifer Richardson is a notable inventor based in Orsay, France. She has made significant contributions to the field of immunology, particularly in the study of feline immunodeficiency virus (FIV). Her work focuses on developing peptides that can aid in the prevention and treatment of this viral infection in cats.

Latest Patents

Jennifer holds a patent for her invention titled "Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications." This patent encompasses peptides encoded by the FIV env gene, which have immunoprophylactic applications. The peptides are capable of inducing a certain degree of protection against FIV infection. They are selected from a specific group consisting of peptides containing 12 to 19 amino acids, including a sequence that corresponds to Lys-Lys-Gly-Leu-Gln-Gln-Leu-Gln-Glu-Trp-Glu-Asp-Trp-Val-Gly-Trp-Ile-Gly-Asn (SEQ ID NO:1). Additionally, the patent includes peptides of not more than 50 amino acids comprising the sequence set forth by SEQ ID NO:1.

Career Highlights

Jennifer is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research. Her work has been instrumental in advancing the understanding of FIV and developing potential therapeutic strategies.

Collaborations

Some of her notable coworkers include Pierre Sonigo and Anne Moraillon, who have collaborated with her on various research projects.

Conclusion

Jennifer Richardson's innovative work in the field of feline immunodeficiency virus research highlights her dedication to improving animal health. Her patented peptides represent a significant advancement in immunoprophylactic applications, showcasing her contributions to veterinary medicine.